Porena M - Search Results

1

Is there any clinical parameter able to predict prostate cancer after initial diagnosis of atypical small acinar proliferation?

Mearini L, Costantini E, Bellezza G, Cavaliere A, Zucchi A, Bini V, Porena M. Mearini L, et al. Among authors: porena m. Urol Int. 2008;81(1):29-35. doi: 10.1159/000137637. Epub 2008 Jul 16. Urol Int. 2008. PMID: 18645268

2

Testosterone levels in benign prostatic hypertrophy and prostate cancer.

Mearini L, Costantini E, Zucchi A, Mearini E, Bini V, Cottini E, Porena M. Mearini L, et al. Among authors: porena m. Urol Int. 2008;80(2):134-40. doi: 10.1159/000112602. Epub 2008 Mar 19. Urol Int. 2008. PMID: 18362481

3

Sensitivity and specificity of one-hour pad test as a predictive value for female urinary incontinence.

Costantini E, Lazzeri M, Bini V, Giannantoni A, Mearini L, Porena M. Costantini E, et al. Among authors: porena m. Urol Int. 2008;81(2):153-9. doi: 10.1159/000144053. Epub 2008 Aug 29. Urol Int. 2008. PMID: 18758212

4

Open-label, longitudinal study of tamsulosin for functional bladder outlet obstruction in women.

Costantini E, Lazzeri M, Bini V, Zucchi A, Fioretti F, Frumenzio E, Porena M. Costantini E, et al. Among authors: porena m. Urol Int. 2009;83(3):311-5. doi: 10.1159/000241674. Epub 2009 Oct 13. Urol Int. 2009. PMID: 19829032 Clinical Trial.

5

Preoperative MUCP and VLPP did not predict long-term (4-year) outcome after transobturator mid-urethral sling.

Costantini E, Lazzeri M, Giannantoni A, Bini V, del Zingaro M, Porena M. Costantini E, et al. Among authors: porena m. Urol Int. 2009;83(4):392-8. doi: 10.1159/000251177. Epub 2009 Dec 8. Urol Int. 2009. PMID: 19996644

6

Bacillus Calmette-Guérin versus gemcitabine for intravesical therapy in high-risk superficial bladder cancer: a randomised prospective study.

Porena M, Del Zingaro M, Lazzeri M, Mearini L, Giannantoni A, Bini V, Costantini E. Porena M, et al. Urol Int. 2010;84(1):23-7. doi: 10.1159/000273461. Epub 2010 Feb 17. Urol Int. 2010. PMID: 20173364 Clinical Trial.

7

Outcomes of radical prostatectomy in clinically locally advanced N0M0 prostate cancer.

Mearini L, Zucchi A, Costantini E, Bini V, Nunzi E, Porena M. Mearini L, et al. Among authors: porena m. Urol Int. 2010;85(2):166-72. doi: 10.1159/000316944. Epub 2010 Jun 18. Urol Int. 2010. PMID: 20558980

8

Intermittent androgen suppression in prostate cancer: testosterone levels and its implication.

Mearini L, Zucchi A, Costantini E, Bini V, Porena M. Mearini L, et al. Among authors: porena m. J Sex Med. 2011 Apr;8(4):1218-27. doi: 10.1111/j.1743-6109.2010.02169.x. Epub 2011 Jan 14. J Sex Med. 2011. PMID: 21235718

9

Low serum testosterone levels are predictive of prostate cancer.

Mearini L, Zucchi A, Nunzi E, Villirillo T, Bini V, Porena M. Mearini L, et al. Among authors: porena m. World J Urol. 2013 Apr;31(2):247-52. doi: 10.1007/s00345-011-0793-x. Epub 2011 Nov 9. World J Urol. 2013. PMID: 22068548

10

Correlation between age and Chromogranin A determination in prostate diseases.

Mearini L, Zucchi A, Scarponi E, Nunzi E, Aglietti MC, Bini V, Porena M. Mearini L, et al. Among authors: porena m. Cancer Biomark. 2011-2012;10(3-4):117-23. doi: 10.3233/CBM-2012-0237. Cancer Biomark. 2011. PMID: 22674297

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters